🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CALL TO ACTION! AMR Accelerator projects ask for long-term investments to preserve the European capacity for antibiotic R&D by sustaining the assets, expertise, and research infrastructures required to develop new treatments for drug-resistant infections! nature.com/articles/d4157…

📢Global Action Needed!🌎 IMI AMR ACCELERATOR - 9 EU projects partnership, including EVI-led #PrIMAVeRa - calls for urgent investment in antibiotic development, emphasising the need for coordinated global action & funding to fight #AMR. 📃Read more: euvaccine.eu/post/preservin…

📢Apply now for #TRANSVACacademy to advance your knowledge in #vaccine R&D! 3⃣ courses available 🔬Cutting-edge tech & methods + Hands-on experience 👩‍🔬#Researchers & Pharma / Students 🌍CEPI -funded scholarships for LMIC applicants! APPLY TODAY👉transvac.org/transvac-cours…

[ALA Client News] Naobios and European Vaccine Initiative (EVI) partner up to manufacture Respiratory Syncytial Virus (RSV) challenge agent ala.associates/partnership/na…[…]-manufacture-respiratory-syncytial-virus-rsv-challenge-agent/ #vaccines #EVI #RSV

📢SUNSHINE trial began on 10.10.24 with the 1st administration of a new #shigellosis #vaccine! Thanks to team efforts of the EVI-led #ShigaPlexIM consortium Leiden University LUMC GRAS-BURKINA CIDRZ NGO Göteborgs universitet / University of Gothenburg PATH /FATH 📝euvaccine.eu/post/shigaplex… EDCTP #EUFunded

Draigon Consortium member, Prof Trish Simner (SimnerLab) of the Johns Hopkins University School of Medicine is taking part in sessions at #IDWeek2024. Watch this space for her thoughts on the 2024 conference take-homes on #AMR! #EUFunded #DRAIGONEU #antimicrobialresistance #AI

Fighting AMR with vaccines 🦠💉 #PrIMAVeRa_amr presented project progress, outcomes, and challenges in epidemiological data access in the EU to Vaccines Europe in Brussels. See meeting highlights, outcomes, and proposals here ➡️primavera-amr.eu/post/primavera…

🌎🦠#AMR is rising, creating a global health crisis. Vaccines can help by reducing the need for antimicrobials in the first place. At EVI we are fighting AMR through initiatives like #PrIMAVeRa, #DRAIGON, #ShigaPlexIM & #ShigETECvax. More➡euvaccine.eu/post/antimicro… #WAAW2024 #WAAW

Catalyst funding for pump-priming projects is now open. BactiVac Network provides funding for projects that catalyse research in bacterial vaccinology. Applications are now open, see our website for full details: bit.ly/CatalystProject Apply by 15 June 2025 #BactiVacFunding

Last week, in collaboration with Impact Global Health, we hosted a session at the Science|Business conference on 'How to accelerate R&D investment for a safer healthier world?’ Read the key takeaways from the session ➡️ sciencebusiness.net/call-europe-st…

The PREV_PKDL consortium held its final meeting in Frankfurt, marking the culmination of collaborative efforts to advance a preventive #vaccine for #DermalLeishmaniasis.🌍 Congratulations to everyone involved in combating this neglected tropical disease. 📝prevpkdl.eu/post/prev-pkdl…

Registration now open! BactiVac Network 6th Annual Network Meeting, Edgbaston Park Hotel Hotel, Birmingham, UK. Register before 22 June 2025 to benefit from the early bird discounted rate: bit.ly/ANM6 #BactiVacEvents Wellcome Medical Research Council College of Medicine and Health (UoB)

Welcome to the final in our series showcasing DRAIGON members. This is the turn of Susannah Hartmann; microbiologist at Orthopedic Hospital Vienna Speising. Hear why she’s really looking forward to ESCMID 12 - 15 April. #DRAIGONEU #AMR #AI #EUFunded

A new part of the immune system has been discovered –called the proteasome–. It gives a new place to look for antibiotics to tackle the growing problem of superbugs that resist current drugs. The research is reported in Nature: doi.org/10.1038/s41586…

Though helpful in wealthier countries, LMICs often lack access to proper diagnostics, leading to overprescription. Capacity building initiatives such as those at UHSN partner in Albania, are central to our mission to support LMICs in combating #AMR through advanced diagnostics.🌍